Almaden J - Search Results

1

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.

Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Freeman-Cook K, et al. Among authors: almaden j. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. Cancer Cell. 2021. PMID: 34520734 Free article.

2

IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner.

Alves BN, Tsui R, Almaden J, Shokhirev MN, Davis-Turak J, Fujimoto J, Birnbaum H, Ponomarenko J, Hoffmann A. Alves BN, et al. Among authors: almaden j. J Immunol. 2014 Apr 1;192(7):3121-32. doi: 10.4049/jimmunol.1302351. Epub 2014 Mar 3. J Immunol. 2014. PMID: 24591377 Free PMC article.

3

A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells.

Almaden JV, Tsui R, Liu YC, Birnbaum H, Shokhirev MN, Ngo KA, Davis-Turak JC, Otero D, Basak S, Rickert RC, Hoffmann A. Almaden JV, et al. Cell Rep. 2014 Dec 24;9(6):2098-111. doi: 10.1016/j.celrep.2014.11.024. Epub 2014 Dec 11. Cell Rep. 2014. PMID: 25497099 Free PMC article.

4

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel.

Almaden JV, Liu YC, Yang E, Otero DC, Birnbaum H, Davis-Turak J, Asagiri M, David M, Goldrath AW, Hoffmann A. Almaden JV, et al. Blood. 2016 Mar 10;127(10):1276-86. doi: 10.1182/blood-2014-10-606988. Epub 2016 Jan 14. Blood. 2016. PMID: 26773039 Free PMC article.

5

A multi-scale approach reveals that NF-κB cRel enforces a B-cell decision to divide.

Shokhirev MN, Almaden J, Davis-Turak J, Birnbaum HA, Russell TM, Vargas JA, Hoffmann A. Shokhirev MN, et al. Among authors: almaden j. Mol Syst Biol. 2015 Feb 13;11(1):783. doi: 10.15252/msb.20145554. Mol Syst Biol. 2015. PMID: 25680807 Free PMC article.

6

Glucose modulation of glucokinase activation by small molecules.

Ralph EC, Thomson J, Almaden J, Sun S. Ralph EC, et al. Among authors: almaden j. Biochemistry. 2008 Apr 29;47(17):5028-36. doi: 10.1021/bi702516y. Epub 2008 Mar 28. Biochemistry. 2008. PMID: 18370405

7

Assay development and data analysis of receptor-ligand binding based on scintillation proximity assay.

Sun S, Almaden J, Carlson TJ, Barker J, Gehring MR. Sun S, et al. Among authors: almaden j. Metab Eng. 2005 Jan;7(1):38-44. doi: 10.1016/j.ymben.2004.05.004. Metab Eng. 2005. PMID: 15721809

8

Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.

Humphries PS, Almaden JV, Barnum SJ, Carlson TJ, Do QQ, Fraser JD, Hess M, Kim YH, Ogilvie KM, Sun S. Humphries PS, et al. Among authors: almaden jv. Bioorg Med Chem Lett. 2006 Dec 1;16(23):6116-9. doi: 10.1016/j.bmcl.2006.08.105. Epub 2006 Sep 18. Bioorg Med Chem Lett. 2006. PMID: 16979341

9

Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.

Humphries PS, Bailey S, Almaden JV, Barnum SJ, Carlson TJ, Christie LC, Do QQ, Fraser JD, Hess M, Kellum J, Kim YH, McClellan GA, Ogilvie KM, Simmons BH, Skalitzky D, Sun S, Wilhite D, Zehnder LR. Humphries PS, et al. Among authors: almaden jv. Bioorg Med Chem Lett. 2006 Dec 1;16(23):6120-3. doi: 10.1016/j.bmcl.2006.08.110. Epub 2006 Sep 14. Bioorg Med Chem Lett. 2006. PMID: 16973358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page